A new book shows how Johnson & Johnson has pushed misleading narratives and suppressed inconvenient findings to sell its ...

As with any new medical guidance, though, it may take some time for this kind of care to be incorporated into standard ...

Chronic pain affects more than 50 million Americans and remains one of the most difficult conditions to treat safely and effectively. While opioids have lo | Drug Discovery And Development ...

New Orleans biotech South Rampart Pharma advances non-opioid pain drug with $8M funding from Ochsner Ventures and Gulf South ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by ...

Gulf South Angels, a New Orleans-based investment network, is investing in non-opioid pain drug startup South Rampart Pharma, ...

You might have a preferred over-the-counter medication that just seems to metabolize effectively in your body to bring down your pain when you need it. Whether your pick is Advil, Aleve, or Tylenol, a ...